Skip to content

Author

Shuang-Yu Li

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Bruceine A attenuates renal tubulointerstitial fibrosis by inhibiting the Wnt7a/PI3K/AKT pathway

Introduction Tubulointerstitial fibrosis (TIF) is a major pathological feature of progressive chronic kidney disease (CKD), yet effective pharmacological therapies remain limited. Bruceine A (BA), a quassinoid isolated from Brucea javanica, has been reported to exert renoprotective effects in glomerular diseases. Howev...

Shuang-Yu Li, Ren-Qing Wang, Tong Wang et al. · 0 citations
Open access Sep 2026

Combined Taraxacum mongolicum and Astragalus polysaccharides attenuate CCl4-induced hepatic fibrosis through modulation of the TLR4/MyD88/NF-κB signaling pathway and gut microbiota composition

TMP combined with APS exerts enhanced anti-hepatic fibrosis effects compared with either monotherapy, and is associated with changes in gut microbiota composition, elevated fecal short-chain fatty acid levels, and reduced expression of hepatic TLR4/MyD88/NF-κB pathway-related molecules.

Yin-Jie Ma, Chao-Xing Wang, Xue Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.